Journal of Drugs in Dermatology

View more issues:

Articles in Dec, 2003 issue of Journal of Drugs in Dermatology

• Narrow B and ultraviolet B radiation therapy for recalcitrant vitiligo in Asians
• Tissue fillers
  by Arnold William Klein
• A possible role for non-ablative radiofrequency in the treatment of rosacea
  by Ivan Ruiz-Esparza
• Imiquimod for the treatment of Bowen's disease and invasive squamous cell carcinoma
  by Keyvan Nouri
• Novel psoriasis treatment to begin Phase I testing
• Beware confusing micrograms and milligrams
  by James Wharton
• Comparing therapy costs for physician treatment of warts
  by Robert J Clemons
• Valtrex approved by FDA for reducing spread of genital herpes
• In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity
• Fixed drug eruption to ibuprofen in daughter and father
  by Khalid Al Aboud
• Topically-administered keratinocyte growth factor-2 will not be developed for the treatment of chronic venous ulcers
• Preoperative monitoring of warfarin in cutaneous surgery
• Errata
• Generalized granuloma annulare in a patient with adult onset diabetes mellitus
  by Robert A Guardiano
• FDA tentatively approves generic fluconazole
• Combination therapy of tetracycline and tacrolimus resulting in rapid resolution of steroid-induced periocular rosacea
• One score and ten PDRs ago: the transformation of medical practice
  by Craig G. Burkhart
• Effect of PTU on IL-12 and IL-10 in psoriasis
  by Alan N Elias
• Raptiva recommended by FDA advisory committee for the treatment of psoriasis
• Observer-blind, randomized, intrapatient comparison of a novel 1% coal tar preparation and calcopotriol cream in the treatment of plaque type psoriasis
• Remittive effects of intramuscular alefacept in psoriasis
  by Kenneth B Gordon
• Reticulate and stellate acral pigmentation associated with systemic lupus erythematosus and high titers of circulating anticardiolipin antibodies: a possible association with acral microlivedo
  by Noah S Scheinfeld
• Novel acne therapy MBI 594AN completes Phase IIB clinical trial
• Clinical trial review
• Hypothesis: superoxide scavengers or superoxide dismutase may potentiate the therapeutic efficacy of contact dermatitis against alopecia areata
  by M.R. Namazi
• Compatibility of desoximetasone and tacrolimus
  by Jacob Levitt
• Cubicin for the treatment of skin infections
• Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis
• The rounded Siegel scalpel handle: a better instrument for curved incisions
  by S Ray Peterson
• Doxycycline-induced photo-onycholysis
  by Lisa A Carroll
• FDA approves Gamunex, Immune Globulin Intravenous , 10% Caprylate/Chromatography Purified
• A usual frameshift and delayed termination codon mutation in keratin 5 causes a novel type of epidermolysis bullosa simplex with migratory circinate erythema
• Short incubation PDT versus 5-FU in treating actinic keratoses
  by Stacy Smith
• Improvement of acanthosis nigricans on isotretinoin and metformin
  by Hobart W Walling
• First topical peptide treatment effective in psoriasis
• A letter from the editor-in-chief
  by Perry Robins
• Photodynamic therapy for molluscum contagiosum infection in HIV-coinfected patients: review of 6 patients
  by Ali Moiin
• Botox reverses the signs of photoaging
  by Neil S Sadick
• Melanoma and melanocytic neoplasia II: a different point of view